Jonathan Kish Selected Research

Jonathan Kish Research Topics

4	Neoplasms (Cancer) 01/2023 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2019
2	Multiple Myeloma 02/2022 - 01/2016
2	Vomiting 11/2021 - 01/2019
2	Nausea 11/2021 - 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 09/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2022
1	Hemolysis 01/2022
1	Bone Marrow Failure Disorders 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Polycythemia Vera 11/2021
1	Triple Negative Breast Neoplasms 11/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Melanoma (Melanoma, Malignant) 09/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Papillomavirus Infections 01/2017
1	Pain (Aches) 08/2016
1	Prostatic Neoplasms (Prostate Cancer) 08/2016

2	ruxolitinibIBA 09/2023 - 11/2021
1	fedratinibIBA 09/2023
1	Poly Adenosine Diphosphate RiboseIBA 01/2023
1	talazoparibIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 02/2022
1	pomalidomideIBA 02/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Complement C5 (Complement 5)IBA 01/2022
1	eculizumab FDA Link 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2021
1	130-nm albumin-bound paclitaxelIBA 11/2020
1	Atrial Natriuretic Factor (ANF)IBA 11/2020
1	atezolizumabIBA 11/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2019
1	Palonosetron (Aloxi)FDA Link 01/2019
1	ElementsIBA 01/2019
1	AntiemeticsIBA 01/2019
1	lime (calcium oxide)FDA Link 01/2017
1	Opioid Analgesics (Opioids)IBA 08/2016

6	Therapeutics 02/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
1	Immunotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2020
1	Palliative Care (Palliative Therapy) 01/2020